Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Little Rock, Arkansas 72202


Purpose:

To assess whether the drug ketamine given prior to cardiopulmonary bypass can decrease injury to the cells in the brain.


Criteria:

Inclusion Criteria: - less than one year of age - undergoing cardiac surgery for repair of ventricular septal defect - requiring cardiopulmonary bypass - not requiring retrogrades cerebral perfusion Exclusion Criteria: - Downs Syndrome


NCT ID:

NCT00556361


Primary Contact:

Principal Investigator
Adnan T Bhutta, MD
Arkansas Children's Hospital Research Institute


Backup Contact:

N/A


Location Contact:

Little Rock, Arkansas 72202
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.